Example: tourism industry
Implementation Process Article 5(3) Nitrosamine

Implementation Process Article 5(3) Nitrosamine

Back to document page

Q&A for the implementation of the Article 5(3) referral. As a result of the call for review to MAHs for authorised medicines or for new MAAs, the MAH/applicant should forthwith inform CAs if N-nitrosamines are identified, irrespective of the amount detected. For

  Implementation

Download Implementation Process Article 5(3) Nitrosamine


Information

Domain:

Source:

Link to this page:

Please notify us if you found a problem with this document:

Other abuse

Advertisement

Related search queries